| Financial Year |
March 31 2023 |
| Monetary Funds |
515,555,865.61 |
| Held-for-trading Financial Assets |
5,000,000.00 |
| Notes Receivable |
37,384,115.24 |
| Accounts Receivable |
1,344,315,626.00 |
| Advances to Suppliers |
81,662,744.17 |
| Other Receivables |
9,824,335.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,402,180,372.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
53,451,633.72 |
| Total Current Assets |
4,543,229,790.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
42,635,607.16 |
| Fixed Assetes |
926,628,955.06 |
| Under-construction Projects |
88,929,167.36 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
297,462,022.86 |
| R&D expenses |
-- |
| Goodwill |
137,666,791.00 |
| Long-Term Deferred and Prepaid Expenses |
4,396,998.69 |
| Deferred Income Tax Assets |
45,608,382.43 |
| Other Non-Current Assets |
9,989,201.89 |
| Sub-Total of Non-Current Assets |
1,563,156,758.48 |
| Total Assets |
6,106,386,548.92 |
| Short-Term Loans |
1,427,743,709.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
50,800,000.00 |
| Accounts Payable |
780,962,574.44 |
| Accounts Received In Advance |
2,611,881.03 |
| Employee Compensation Payable |
55,177,313.60 |
| Taxes Payable |
80,458,960.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
918,584,135.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
154,305,763.48 |
| Other Current Liabilities |
33,226,651.99 |
| Sub-Total of Current Liabilities |
3,670,074,434.82 |
| Long-term Loans |
601,598,899.96 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
30,435,506.43 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,352,308.99 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
640,386,715.38 |
| Total Liabilities |
4,310,461,150.20 |
| Paid-In Capital(Or Share Stock) |
339,139,100.00 |
| Capital Surplus |
920,491,507.09 |
| Surplus Reserve |
86,641,078.69 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
415,725,798.65 |
| Minority Stockholder's Interest |
33,948,279.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,761,977,119.58 |
| Owner's Equity（Stockholder's Equity） |
1,795,925,398.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,106,386,548.92 |
